Dr. Michael Davidson

ABOUT MICHAEL DAVIDSON, M.D.

Heart disease remains the leading cause of death worldwide, yet the conversation often overlooks a silent, potent contributor—environmental toxins. Microplastics, PFAS, heavy metals, and other pollutants infiltrate the body daily, fueling chronic inflammation and damaging arteries at the cellular level. Dr. Michael Davidson has spent his career on the front lines of cardiovascular health, committed to advancing strategies that address both traditional and emerging risk factors.

Board-certified in Internal Medicine, Cardiology, and Clinical Lipidology, Dr. Davidson serves as Director of the Lipid Clinic at the University of Chicago Pritzker School of Medicine and is consistently named among “Best Doctors in America.” A biotech innovator, he co-founded Omthera Pharmaceuticals (acquired by AstraZeneca) and Corvidia Therapeutics (acquired by Novo Nordisk), and is the Co-founding CEO of NewAmsterdam Pharma, leading the development of next-generation LDL-cholesterol–lowering therapies.

Dr. Davidson sees therapeutic plasma exchange (TPE)—the foundation of MDLifespan’s Heart PlasmaXchange Protocol—as a powerful, physician-led approach to reducing cardiovascular toxin burden. By removing microplastics, heavy metals, and inflammatory proteins from the bloodstream, TPE may help improve vascular function, reduce systemic inflammation, and optimize cholesterol management. “Toxins are a known cause of inflammation, and removing all the toxins from the body is absolutely in the best benefit of your heart,” he affirms.

MDLifespan’s data underscores this potential: over 300 successful TPE procedures in the past year have shown measurable improvements in cardiovascular biomarkers, with results including up to 100% decrease in heavy metals, 90% decrease in microplastics, and 80% reduction in chronic inflammation.

🎧 Listen to Dr. Davidson on The TPE Blueprint Podcast as he discusses the intersection of toxins, inflammation, and cardiovascular health, and why detoxification strategies deserve a place in preventive cardiology. Listen here →

As a member of the MDLifespan Advisory Board, Dr. Davidson brings unparalleled expertise in lipidology and cardiovascular innovation, helping guide protocols that protect the heart in a toxin-saturated world.